UNSPSC 51132001: Pentoxifylline

This classification denotes a phosphodiesterase inhibitor and antiplatelet agent and alkaloid with the molecular formula C13H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SD6QCT3TSU, chemically known as 1,2,3,6-tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion but generally known as pentoxifylline, which bears US NIH Compound Identifier 4740. European Medicines Agency schedules Pentoxifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09705MIG.

UNSPSC 51132001 Pentoxifylline is a Commodity code that in recent state and local procurement activity bears no material connection to its pharmaceutical scope. The single recent opportunity tagged under this code—Sourcewell's RFP #061626, posted May 12, 2026 with a response deadline of June 16, 2026—solicits law enforcement equipment on behalf of a multi-state cooperative purchasing vehicle, not pharmaceutical products. The mismatch between the code's nominal scope (pentoxifylline, a peripheral vasodilator medication) and the actual procurement (law enforcement gear) suggests the code is either miscoded in the state and local system or sees minimal relevant activity. No other recent opportunities in the source block clarify the code's actual use in state and local procurement.

Sourcewell, a State of Minnesota local government unit and service cooperative, issued the RFP under Washington state law (RCW 39.34) to establish a blanket contracting vehicle available to thousands of governmental entities across the United States and Canada, including Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County, as well as higher education institutions, K-12 school districts, nonprofit organizations, and tribal governments. Proposals were due June 16, 2026 at 3:30 p.m. Central Time through the Sourcewell Procurement Portal. The cooperative structure allows selected vendors broad market access across participating jurisdictions, but the solicitation does not identify specific award values, set-aside designations, or budget ranges. Given the fundamental disconnect between the code definition and the single recent opportunity, this code shows little reliable signal for pharmaceutical procurement targeting and warrants verification before pursuit.